Clariant AG (CLN) Earnings Call Transcripts
Clariant AG's Latest Earnings Call - Q1 FY2026
In Q1 2026, Clariant AG reported sales of CHF 918 million, a 2% decrease in local currencies, primarily impacted by the ongoing Middle East conflict and portfolio pruning actions. EBITDA before exceptional items fell 16% to CHF 160 million, resulting in a margin of 17.5%. Management maintained its full-year guidance, expecting sales to remain flat in local currency and an EBITDA margin of around 18%, indicating resilience amid challenging market conditions and inflationary pressures.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | CHF 918 million (miss) |
| EBITDA | CHF 160 million (miss) |
| EBITDA Margin | 17.5% (miss) |
| Free Cash Flow Conversion | over 40% (inline) |
| Cost Savings from Performance Program | CHF 59 million (positive) |
| Sales Growth in Care Chemicals | 3.5% underlying volume growth (positive) |
Guidance from management
Management expects sales to remain flat in local currency for 2026 and an EBITDA margin of around 18%. They anticipate continued inflationary pressures but are confident in offsetting these through pricing strategies and cost management.
What management said
Thank you, Conrad and Oliver. Ladies and gentlemen, we are now opening the floor for questions. To ensure everyone has a chance to participate. Please ask no more than 2 questions per person. Thank you for your cooperation. Valentina, please go ahead.
Yes, sorry. Prebuying that was more limited for us in Care Chemicals. We have seen a little bit of prebuying in Personal & [ Home ] Care and also in industrial applications, but that was not a significant contributor in the first quarter.
What analysts pressed on
Analysts expressed concerns regarding the visibility of order books in the Catalyst division, particularly in light of the ongoing Middle East conflict and its impact on customer demand. There were also questions about the potential for further feedstock shortages if the geopolitical situation does not stabilize.
Main topics on the call
- Impact of Middle East Conflict — The ongoing conflict in the Middle East has significantly affected Clariant's operations, particularly in the Catalyst business, with management noting that '44 involve Clariant customers, predominantly in the Middle Eas...
- Cost Management and Pricing Strategy — Clariant is implementing a value-based pricing strategy to counteract inflationary pressures, with management stating, 'We activated our proven value-based price management.' This approach aims to offset rising raw mater...
- Performance Improvement Program — The company is ahead of schedule with its performance improvement program, expecting to achieve full run rate savings of CHF 80 million by the end of 2026, one year earlier than planned. Management highlighted that 'in Q...
- Sales and Volume Trends — Sales in Q1 decreased by 2% in local currency, with volumes down 0.5%. Management noted that 'pricing decreased by 1.5%, mainly driven by formula-based pricing adjusting to lower raw material prices.' This reflects a cha...
Read the full Clariant AG transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Clariant AG
Clariant AG (CLN) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on SWX and is based in CH. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 28 calls on record spanning February 13, 2020 to July 31, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 28 Clariant AG earnings call transcripts on record, spanning February 13, 2020 to July 31, 2026. Based on this history, Clariant AG reports quarterly. The most recent call on file is dated July 31, 2026. The full list is below — each row opens the complete, free-to-read transcript.